Rabaptin-5 regulates receptor expression and functional activation in mast cells

Blood

Volumn 112, Issue 10, 2008, Pages 4148-4157

  Rios, Eon J ^a   Piliponsky, Adrian M ^b   Ra, Chisei ^b   Kalesnikoff, Janet ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA1 INTEGRIN; IMMUNOGLOBULIN E RECEPTOR; RAB PROTEIN; RABAPTIN 5 PROTEIN; RABGEF1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RABEP1 PROTEIN, MOUSE; RABGEF1 PROTEIN, MOUSE; SMALL INTERFERING RNA; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CELL FUSION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS; ANTIGENS, CD29; ENDOCYTOSIS; ENDOSOMES; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MAST CELLS; MICE; RAB5 GTP-BINDING PROTEINS; RECEPTORS, IGE; RNA, SMALL INTERFERING; VESICULAR TRANSPORT PROTEINS;

EID: 58149143302     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-152660     Document Type: Article

References (53)

1. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173:131-140.
2. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23: 749-786.
3. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol. 2006; 117:1214-1225, quiz 1226.
4. Kraft S, Kinet JP. New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol. 2007;7:365-378.
5. Di Fiore PP, Gill GN. Endocytosis and mitogenic signaling. Curr Opin Cell Biol. 1999;11:483-488.
6. Schneider IC, Haugh JM. Mechanisms of gradient sensing and chemotaxis: conserved pathways, diverse regulation. Cell Cycle. 2006;5: 1130-1134.
7. Yamasaki S, Ishikawa E, Kohno M, Saito T. The quantity and duration of FcRgamma signals determine mast cell degranulation and survival. Blood. 2004;103:3093-3101.
8. Seabra MC, Mules EH, Hume AN. Rab GTPases, intracellular traffic and disease. Trends Mol Med. 2002;8:23-30.
9. Novick P, Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol. 1997;9: 496-504.
10. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2001;2:107-117.
11. Pfeffer SR. Rab GTPases: specifying and deciphering organelle identity and function. Trends Cell Biol. 2001;11:487-491.
12. Mizuno K, Tolmachova T, Ushakov DS, et al. Rab27b regulates mast cell granule dynamics and secretion. Traffic. 2007;8:883-892.
13. Neeft M, Wieffer M, de Jong AS, et al. Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells. Mol Biol Cell. 2005;16:731-741.
14. Oberhauser AF, Monck JR, Balch WE, Fernandez JM. Exocytotic fusion is activated by Rab3a peptides. Nature. 1992;360:270-273.
15. Roa M, Paumet F, Le Mao J, David B, Blank U. Involvement of the ras-like GTPase rab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (Fc epsilonRI). J Immunol. 1997;159:2815-2823.
16. Tam SY, Tsai M, Snouwaert JN, et al. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat Immunol. 2004;5:844-852.
17. Kalesnikoff J, Rios EJ, Chen CC, et al. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A. 2006;103:2659-2664.
18. Kalesnikoff J, Rios EJ, Chen CC, et al. Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RIdependent responses in mast cells. Blood. 2007; 109:5308-5317.
19. Mattera R, Tsai YC, Weissman AM, Bonifacino JS. The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J Biol Chem. 2006;281:6874-6883.
20. Stenmark H, Vitale G, Ullrich O, Zerial M. Rabaptin- 5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell. 1995;83:423-432.
21. Lippe R, Miaczynska M, Rybin V, Runge A, Zerial M. Functional synergy between Rab5 effector Rabaptin-5 and exchange factor Rabex-5 when physically associated in a complex. Mol Biol Cell. 2001;12:2219-2228.
22. Pagano A, Crottet P, Prescianotto-Baschong C, Spiess M. In vitro formation of recycling vesicles from endosomes requires adaptor protein-1/clathrin and is regulated by rab4 and the connector rabaptin-5. Mol Biol Cell. 2004;15:4990-5000.
23. Deneka M, Neeft M, Popa I, et al. Rabaptin-5alpha/ rabaptin-4 serves as a linker between rab4 and gamma(1)-adaptin in membrane recycling from endosomes. EMBO J. 2003;22:2645-2657.
24. van der Sluijs P, Mohrmann K, Deneka M, Jongeneelen M. Expression and properties of Rab4 and its effector rabaptin-4 in endocytic recycling. Methods Enzymol. 2001;329:111-119.
25. Brown JM, Wilson TM, Metcalfe DD. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy. 2008;38:4-18.
26. Howarth M, Chinnapen DJ, Gerrow K, et al. A monovalent streptavidin with a single femtomolar biotin binding site. Nat Methods. 2006;3:267-273.
27. Lam V, Kalesnikoff J, Lee CW, et al. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood. 2003;102:1405-1413.
28. Korobko EV, Kiselev SL, Korobko IV. Multiple rabaptin-5-like transcripts. Gene. 2002;292:191- 197.
29. Horiuchi H, Lippe R, McBride HM, et al.Anovel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell. 1997;90:1149-1159.
30. Blank U, Ra CS, Kinet JP. Characterization of truncated alpha chain products from human, rat, and mouse high affinity receptor for immunoglobulin E. J Biol Chem. 1991;266:2639-2646.
31. Borkowski TA, Jouvin MH, Lin SY, Kinet JP. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol. 2001;167: 1290-1296.
32. Kuster H, Thompson H, Kinet JP. Characterization and expression of the gene for the human Fc receptor gamma subunit: definition of a new gene family. J Biol Chem. 1990;265:6448-6452.
33. Kubo S, Matsuoka K, Taya C, et al. Drastic upregulation of FcepsilonRI on mast cells is induced by IgE binding through stabilization and accumulation of FcepsilonRI on the cell surface. J Immunol. 2001;167:3427-3434.
34. MacGlashan DW Jr. Endocytosis, recycling, and degradation of unoccupied FcεRI in human basophils. J Leukoc Biol. 2007;82:1003-1010.
35. Mellman IS. Endocytosis, membrane recycling and Fc receptor function. Ciba Found Symp. 1982;35-58.
36. Tesar DB, Tiangco NE, Bjorkman PJ. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic. 2006;7:1127-1142.
37. Hsu C, MacGlashan DW Jr. IgE antibody upregulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett. 1996; 52:129-134.
38. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med. 1997;185:663-672.
39. Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic. 2006;7:14-21.
40. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstein LM. IgE receptors on human basophils: relationship to serum IgE concentration. J Clin Invest. 1978;62:176-181.
41. Zhu H, Zhu G, Liu J, Liang Z, Zhang XC, Li G. Rabaptin-5-independent membrane targeting and Rab5 activation by Rabex-5 in the cell. Mol Biol Cell. 2007;18:4119-4128.
42. Nogi T, Shiba Y, Kawasaki M, et al. Structural basis for the accessory protein recruitment by the gamma-adaptin ear domain. Nat Struct Biol. 2002;9:527-531.
43. Shiba Y, Takatsu H, Shin HW, Nakayama K. Gamma-adaptin interacts directly with Rabaptin-5 through its ear domain. J Biochem (Tokyo). 2002; 131:327-336.
44. Zhu G, Zhai P, He X, et al. Crystal structure of human GGA1 GAT domain complexed with the GAT-binding domain of Rabaptin5. EMBO J. 2004;23:3909-3917.
45. Mattera R, Arighi CN, Lodge R, Zerial M, Bonifacino JS. Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5 complex. EMBO J. 2003;22:78-88.
46. Zhai P, He X, Liu J, et al. The interaction of the human GGA1 GAT domain with rabaptin-5 is mediated by residues on its three-helix bundle. Biochemistry. 2003;42:13901-13908.
47. Korobko EV, Palgova IV, Kiselev SL, Korobko IV. Apoptotic cleavage of rabaptin-5-like proteins and a model for rabaptin-5 inactivation in apoptosis. Cell Cycle. 2006;5:1854-1858.
48. Swanton E, Bishop N, Woodman P. Human rabaptin-5 is selectively cleaved by caspase-3 during apoptosis. J Biol Chem. 1999;274:37583- 37590.
49. Cosulich SC, Horiuchi H, Zerial M, Clarke PR, Woodman PG. Cleavage of rabaptin-5 blocks endosome fusion during apoptosis. EMBO J. 1997; 16:6182-6191.
50. Bousquet J, Rabe K, Humbert M, et al. Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med. 2007;101:1483-1492.
51. Casale TB, Stokes JR. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol. 2008;121:288-296, quiz 297-298.
52. Mirkina I, Schweighoffer T, Kricek F. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab. Immunol Lett. 2007;109:120-128.
53. Takai T, Yuuki T, Ra C. Inhibition of IgEdependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain. Int Arch Allergy Immunol. 2000;123:308-318.